O	0	9	Perceived
O	10	16	stress
O	17	26	moderates
O	27	30	the
O	31	38	effects
O	39	41	of
O	42	43	a
O	44	54	randomized
O	55	60	trial
O	61	63	of
B-intervention	64	69	dance
I-intervention	70	78	movement
I-intervention	79	86	therapy
O	87	89	on
B-condition	90	97	diurnal
I-condition	98	106	cortisol
I-condition	107	113	slopes
O	114	116	in
O	117	123	breast
O	124	130	cancer
O	131	139	patients
O	139	140	.

O	141	146	Women
O	147	151	with
O	152	158	breast
O	159	165	cancer
O	166	169	are
O	170	172	at
O	173	177	risk
O	178	180	of
O	181	193	psychosocial
O	194	202	distress
O	203	206	and
O	207	210	may
O	211	217	suffer
O	218	222	from
O	223	231	aberrant
O	232	239	diurnal
O	240	248	cortisol
O	249	256	rhythms
O	256	257	.

O	258	263	Dance
O	264	272	movement
O	273	280	therapy
O	281	282	(
O	282	285	DMT
O	285	286	)
O	286	287	,
O	288	289	a
O	290	298	movement
O	298	299	-
O	299	304	based
O	305	318	psychotherapy
O	319	323	that
O	324	336	incorporates
O	337	345	exercise
O	346	349	and
O	350	358	artistic
O	359	369	components
O	369	370	,
O	371	374	has
O	375	387	demonstrated
O	388	394	stress
O	395	404	reduction
O	405	412	effects
O	412	413	.

O	414	418	This
O	419	424	study
O	425	433	examined
O	434	437	the
O	438	445	effects
O	446	448	of
O	449	452	DMT
O	453	455	on
O	456	459	the
O	460	467	diurnal
O	468	476	cortisol
O	477	484	rhythms
O	485	487	of
B-eligibility	488	494	breast
I-eligibility	495	501	cancer
I-eligibility	502	510	patients
I-eligibility	511	521	undergoing
I-eligibility	522	534	radiotherapy
I-eligibility	535	544	treatment
O	545	548	and
O	549	552	the
O	553	557	role
O	558	560	of
O	561	570	perceived
O	571	577	stress
O	578	580	in
O	581	590	producing
O	591	595	such
O	596	603	effects
O	603	604	.

O	605	608	The
O	609	614	study
O	615	621	sample
O	622	631	comprised
B-total-participants	632	635	121
B-ethinicity	636	643	Chinese
O	644	650	breast
O	651	657	cancer
O	658	666	patients
O	667	677	randomized
O	678	680	to
O	681	684	the
O	685	688	DMT
O	689	690	(
O	690	691	n
O	691	692	=
B-intervention-participants	692	694	63
O	694	695	)
O	696	699	and
B-control	700	707	control
O	708	709	(
O	709	710	n
O	710	711	=
B-control-participants	711	713	58
O	713	714	)
O	715	721	groups
O	721	722	.

O	723	726	The
O	727	739	intervention
O	740	749	consisted
O	750	752	of
O	753	756	six
O	757	758	1
O	758	759	.
O	759	760	5
O	760	761	-
O	761	762	h
O	763	768	group
O	769	777	sessions
O	778	782	held
O	783	788	twice
O	789	795	weekly
O	796	800	over
O	801	804	the
O	805	811	course
O	812	814	of
O	815	827	radiotherapy
O	827	828	.

O	829	841	Participants
O	842	851	completed
O	852	861	validated
O	862	866	self
O	866	867	-
O	867	873	report
O	874	882	measures
O	883	885	of
O	886	895	perceived
O	896	902	stress
O	902	903	,
O	904	911	fatigue
O	911	912	,
O	913	917	pain
O	917	918	,
O	919	922	and
O	923	928	sleep
O	929	940	disturbance
O	941	944	and
O	945	953	provided
O	954	958	five
O	959	967	salivary
O	968	976	cortisol
O	977	984	samples
O	985	987	at
O	988	996	baseline
O	997	998	(
O	998	1002	Time
O	1003	1004	1
O	1004	1005	)
O	1006	1009	and
O	1010	1014	post
O	1014	1015	-
O	1015	1027	intervention
O	1028	1029	(
O	1029	1033	Time
O	1034	1035	2
O	1035	1036	)
O	1036	1037	.

O	1038	1047	Moderated
O	1048	1057	mediation
O	1058	1066	analysis
O	1067	1070	was
O	1071	1075	used
O	1076	1078	to
O	1079	1087	evaluate
O	1088	1091	the
O	1092	1104	intervention
O	1105	1111	effect
O	1112	1114	on
O	1115	1119	Time
O	1120	1121	2
O	1122	1129	diurnal
O	1130	1138	cortisol
O	1139	1145	slopes
O	1145	1146	.

O	1147	1154	Despite
O	1155	1158	the
O	1159	1166	absence
O	1167	1169	of
O	1170	1171	a
O	1172	1183	significant
O	1184	1187	DMT
B-outcome	1188	1194	effect
I-outcome	1195	1197	on
I-outcome	1198	1205	diurnal
I-outcome	1206	1214	cortisol
I-outcome	1215	1221	slopes
O	1222	1223	(
O	1223	1224	B
O	1224	1225	=
O	1225	1226	-
O	1226	1227	0
O	1227	1228	.
O	1228	1230	55
O	1230	1231	,
O	1232	1234	95
O	1234	1235	%
O	1236	1238	CI
O	1238	1239	=
O	1239	1240	-
O	1240	1241	1
O	1241	1242	.
O	1242	1244	20
O	1245	1247	to
O	1248	1249	0
O	1249	1250	.
O	1250	1252	08
O	1252	1253	,
O	1254	1255	β
O	1255	1256	=
O	1256	1257	-
O	1257	1258	0
O	1258	1259	.
O	1259	1261	14
O	1261	1262	)
O	1262	1263	,
O	1264	1272	baseline
B-outcome	1273	1282	perceived
I-outcome	1283	1289	stress
O	1290	1303	significantly
O	1304	1313	moderated
O	1314	1317	the
O	1318	1330	intervention
O	1331	1337	effect
O	1338	1339	(
O	1339	1340	B
O	1340	1341	=
O	1341	1342	-
O	1342	1343	0
O	1343	1344	.
O	1344	1346	18
O	1346	1347	,
O	1348	1350	95
O	1350	1351	%
O	1352	1354	CI
O	1354	1355	=
O	1355	1356	-
O	1356	1357	0
O	1357	1358	.
O	1358	1360	32
O	1361	1363	to
O	1364	1365	-
O	1365	1366	0
O	1366	1367	.
O	1367	1369	05
O	1369	1370	,
O	1371	1372	β
O	1372	1373	=
O	1373	1374	-
O	1374	1375	0
O	1375	1376	.
O	1376	1378	30
O	1378	1379	)
O	1379	1380	.

O	1381	1383	At
O	1384	1388	high
O	1389	1395	levels
O	1396	1398	of
B-outcome	1399	1407	baseline
I-outcome	1408	1417	perceived
I-outcome	1418	1424	stress
O	1425	1426	(
O	1426	1427	1
O	1428	1430	SD
O	1431	1436	above
O	1437	1440	the
O	1441	1445	mean
O	1445	1446	)
O	1446	1447	,
O	1448	1451	the
O	1452	1455	DMT
O	1456	1461	group
O	1462	1468	showed
O	1469	1470	a
O	1471	1478	steeper
O	1479	1487	cortisol
O	1488	1493	slope
O	1494	1495	(
O	1495	1496	M
O	1496	1497	=
O	1497	1498	-
O	1498	1499	7
O	1499	1500	.
O	1500	1502	14
O	1502	1503	)
O	1504	1508	than
O	1509	1512	the
O	1513	1520	control
O	1521	1526	group
O	1527	1528	(
O	1528	1529	M
O	1529	1530	=
O	1530	1531	-
O	1531	1532	5
O	1532	1533	.
O	1533	1535	80
O	1535	1536	)
O	1537	1539	at
O	1540	1544	Time
O	1545	1546	2
O	1546	1547	.

O	1548	1551	The
O	1552	1559	present
O	1560	1568	findings
O	1569	1576	suggest
O	1577	1581	that
O	1582	1585	DMT
O	1586	1591	might
O	1592	1596	have
O	1597	1598	a
O	1599	1609	beneficial
O	1610	1616	effect
O	1617	1619	on
O	1620	1627	diurnal
O	1628	1636	cortisol
O	1637	1643	slopes
O	1644	1646	in
O	1647	1653	breast
O	1654	1660	cancer
O	1661	1669	patients
O	1670	1674	with
O	1675	1679	high
O	1680	1686	levels
O	1687	1689	of
O	1690	1698	distress
O	1698	1699	.
